Meitheal Pharmaceuticals, Inc.

Meitheal Pharmaceuticals, Inc.

Pharmaceutical Manufacturing

Chicago, Illinois 7,762 followers

Spanning the spectrum of what it takes to bring generic drugs to market.

About us

Founded in 2017, Meitheal Pharmaceuticals is a privately owned pharmaceutical company focusing on generic injectable products. Headquartered near Chicago, Illinois, Meitheal has an established management team and an aggressive growth strategy. Through global partnerships, our goal is to bring supply to US healthcare providers that demand a reliable, high quality, yet affordable supply of injectables.

Industry
Pharmaceutical Manufacturing
Company size
51-200 employees
Headquarters
Chicago, Illinois
Type
Privately Held
Founded
2017
Specialties
Acquisitions, Sales, Licensing, Distribution, and Marketing

Locations

  • Primary

    8700 W Bryn Mawr Ave

    Suite 600S

    Chicago, Illinois 60631, US

    Get directions

Employees at Meitheal Pharmaceuticals, Inc.

Updates

  • American Society of Reproductive Medicine Convention Denver, CO | October 19-23 Colorado Convention Center Denver, known for its breathtaking mountains and vibrant outdoor culture, provides the perfect backdrop for this year’s American Society of Reproductive Medicine (ASRM) Convention. We're excited to connect with leading fertility experts and discuss groundbreaking advancements in reproductive health. At Meitheal, we are committed to supporting fertility treatments by expanding access to generics, biologics, and biosimilars that help individuals and families on their fertility journeys. We’re looking forward to sharing how our innovations are contributing to a brighter future for reproductive medicine. Meitheal Fertility, for the common good. #Fertility #Generics #Biologics #Biosimilars

    • No alternative text description for this image
  • Virginia Society of Health-System Pharmacists Conference Williamsburg, VA | October 17-19 Kingsmill Resort Williamsburg, Virginia—steeped in history and tradition—serves as the perfect setting for this year's Virginia Society of Health-System Pharmacists (VSHP) Conference. We're excited to join our peers in this important forum to discuss the evolving landscape of pharmacy practice and healthcare. At Meitheal, we are committed to advancing generics, expanding into biologics and biosimilars, and improving access to essential medicines. We look forward to connecting with you and sharing how our innovations support health systems and patient care. Think sustainability. Think Meitheal. #Generics #Biosimilars #Biologics

    • No alternative text description for this image
  • Infectious Disease Week Los Angeles, CA | October 16-19 Los Angeles Convention Center Los Angeles, a city renowned for its entertainment and Hollywood elite, sets the stage for this year’s Infectious Disease Week. We’re excited to join experts from around the world to discuss advancements in the fight against infectious diseases and share our latest contributions to this critical field. At Meitheal, we are committed to developing solutions that expand access to generics, biologics, and biosimilars, including life-saving treatments for infectious diseases. We look forward to engaging with the global healthcare community and sharing how our innovations are making an impact. Think sustainability. Think Meitheal. #DTLA #Generics #Biologics #Biosimilars

    • No alternative text description for this image
  • Global Labeling & Regulatory Symposium Washington, DC | October 8-9 Kimpton Hotel Monaco Washington, DC, renowned for its leadership and innovation, is the perfect backdrop for this year’s Global Labeling & Regulatory Symposium. We’re excited to join industry leaders to discuss the future of healthcare and regulatory advancements. At Meitheal, we are focused on driving innovation in generics, expanding into biologics and biosimilars, and improving access to life-saving medicines. We look forward to connecting with you and sharing how our regulatory strategies are shaping a more sustainable future. Think sustainability, think Meitheal. #Generics #Biologics #Biosimilars

    • No alternative text description for this image

Similar pages

Browse jobs

Funding

Meitheal Pharmaceuticals, Inc. 1 total round

Last Round

Debt financing

US$ 35.0M

Investors

JP Morgan
See more info on crunchbase